<i>In vitro</i> activity of olorofim against clinical isolates of <i>Scedosporium</i> species and <i>Lomentospora prolificans</i> using EUCAST and CLSI methodologies

Abstract

Olorofim displayed promising in vitro activity against the Scedosporium and L. prolificans strains tested, some of which have reduced susceptibility to the antifungals that are currently in use.